C$0.04 AI/ML Innovations (AIML.CN CNQ) 23 Feb 2026 Market Hours: risk signal
AIML.CN stock trades at C$0.04 on the CNQ during market hours on 23 Feb 2026, reflecting thin liquidity and large historical volatility. We note daily volume of 183,250 shares versus a 50-day average near 0.04 and a market cap of C$6,730,560.00, underscoring micro-cap status in Healthcare AI. Investors should weigh the firm’s patent-pending digital health proposition against negative earnings and limited free cash flow. As an AI-powered market analysis platform, Meyka AI monitors AIML.CN stock for short-term momentum and structural risks in the AI-healthcare niche.
AIML.CN stock: market snapshot and price action
We see AIML.CN stock at C$0.04 with no intraday change, a day low and high both at C$0.04 and year range C$0.03–C$0.12. The 50-day and 200-day averages are about C$0.04 and C$0.05 respectively, showing the recent drift lower. Volume today of 183,250 is below the average 388,552, which points to muted trading interest and thin bid depth.
Business model, sector fit and recent news for AIML.CN stock
AI/ML Innovations Inc. operates in digital healthcare with a patent-pending personal health monitoring system and wearable technologies. The company is listed on CNQ and headquartered in Victoria, Canada, placing it in the Healthcare sector and Medical – Healthcare Information Services industry. Broader AI industry coverage remains active (WSJ AI news and the company website provides product context (AI/ML Innovations).
AIML.CN stock: financials, valuation and key metrics
Trailing metrics show EPS -0.03 and PE -1.33, reflecting persistent losses. Price-to-sales sits near 40.00 and price-to-book near 5.23, signaling rich valuation relative to tiny revenue per share (0.00) and book value per share 0.01. Cash per share is 0.01 and current ratio is 2.09, which gives short-term liquidity but limited operational cash generation. The company reports negative operating cash flow per share of -0.03, underlining continued cash burn.
Technical and trading view on AIML.CN stock
Short-term indicators are mixed: RSI around 59.10 suggests mild bullish momentum while ADX at 15.41 shows no strong trend. Bollinger Bands narrow near C$0.03–C$0.04, consistent with low volatility. Average daily volume falls below the 50-day mean, increasing execution risk for larger orders. Traders should expect wide spreads and use limit orders given the micro-cap listing on CNQ.
Meyka AI rates AIML.CN with a score out of 100 and forecast
Meyka AI rates AIML.CN with a score out of 100: Score: 62.19 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly target of C$0.02 and a yearly target of C$0.0084, versus the current C$0.04, implying a monthly downside of -50.00% and a yearly downside near -78.92%. Forecasts are model-based projections and not guarantees.
Risks and catalysts for AIML.CN stock
Key risks include limited revenue scale, negative margins, and thin liquidity that magnify price moves. Material catalysts would be revenue contracts, regulatory clarity for digital health devices, or meaningful R&D partnerships. Sector shifts in AI healthcare adoption or a successful pilot could push the stock toward the year high C$0.12, while missed milestones would likely pressure the price below C$0.03.
Final Thoughts
AIML.CN stock trades at C$0.04 and shows a micro-cap profile with high execution risk, negative earnings (EPS -0.03) and limited free cash flow. Our view frames AIML as a speculative AI-healthcare exposure where upside depends on commercialization or partnership catalysts. Realistic near-term price targets for active investors could be a conservative bear C$0.02 (implied downside -50.00%), a base case C$0.05 (upside 25.00%), and a bull case tied to prior highs at C$0.12 (upside 200.00%). Meyka AI’s forecast model projects C$0.02 monthly and C$0.0084 yearly, which implies significant downside from the current quote and underlines the model’s caution. These forecasts are model-based projections and not guarantees. Given the Healthcare sector averages and the company’s valuation ratios, we recommend cautious position sizing and clear exit rules for short-term traders. For more detail, see the company site and our real-time coverage on the Meyka AI platform at Meyka AIML.CN page.
FAQs
What is the current price of AIML.CN stock and its trading status?
AIML.CN stock is trading at C$0.04 on CNQ during market hours on 23 Feb 2026 with volume 183,250, below its 50-day average. The listing shows thin liquidity and both day low and high at C$0.04.
What are the main valuation concerns for AIML.CN stock?
Valuation concerns include EPS -0.03, PE -1.33, price-to-sales 40.00 and price-to-book 5.23, reflecting losses, tiny revenue, and a stretched valuation versus fundamentals. These metrics indicate high risk for investors.
What forecast does Meyka AI give for AIML.CN stock?
Meyka AI’s forecast model projects C$0.02 monthly and C$0.0084 yearly for AIML.CN stock, implying downside of -50.00% and -78.92% respectively. Forecasts are model-based projections and not guarantees.
What catalysts could move AIML.CN stock higher?
Positive catalysts include commercial contracts for the monitoring system, clinical validation milestones, partnerships with healthcare providers, or broader AI-healthcare adoption. Any clear revenue trajectory would materially reduce risk.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.